Exploring how clonal hematopoiesis affects neurodegenerative diseases like Alzheimer's and ALS
Unraveling the Role of Clonal Hematopoiesis in Neurodegenerative Diseases
This study is looking at how a specific blood cell change called clonal hematopoiesis might affect the risk and progression of Alzheimer's disease and ALS, and it hopes to find new ways to prevent or treat these conditions, with the help of patients who can provide samples.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11158439 on NIH RePORTER |
What this research studies
This research investigates the role of clonal hematopoiesis (CH) in neurodegenerative diseases, particularly Alzheimer's disease and amyotrophic lateral sclerosis. By analyzing high-throughput sequencing data, the study aims to understand how different types of CH may influence the risk and progression of these conditions. The research will also explore the underlying mechanisms of CH's effects on neurodegeneration, potentially leading to new insights into disease prevention and treatment. Patients may be involved in providing biological samples to help elucidate these relationships.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with Alzheimer's disease, Parkinson's disease, or amyotrophic lateral sclerosis.
Not a fit: Patients with neurodegenerative diseases not related to clonal hematopoiesis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating neurodegenerative diseases.
How similar studies have performed: Previous research has shown promising results regarding the protective effects of clonal hematopoiesis in Alzheimer's disease, suggesting potential for further exploration in this area.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Raj, Towfique — Icahn School of Medicine at Mount Sinai
- Study coordinator: Raj, Towfique
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.